Alnylam Pharmaceuticals, Inc. (ALNY)

332.92 +1.68 (+0.51%) USD  |  NASDAQ  |  Feb 27, 16:00
332.92 0.00 (0.00%) Pre-Market: 08:15
More

Alnylam Pharmaceuticals Stock Based Compensation (Annual Per Share)

Stock Based Compensation (Annual Per Share) Chart

View Stock Based Compensation (Annual Per Share) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual Per Share) Range, Past 5 Years

View Stock Based Compensation (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual Per Share) Benchmarks

View Stock Based Compensation (Annual Per Share) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Biogen, Inc. Upgrade
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade